Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 4618 participants.

Also called NCT04297592

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 4,618 participants (planned count) (from the registry)
Sponsor
  • Mayo Clinic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04297592
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT04297592. Randomized; no masking; primary purpose prevention. Start 2020-06-11 (actual); primary completion 2027-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Condition
Infections Joint Prosthetic
Condition
Overweight or Obesity
Condition
MSSA Colonization
Condition
MRSA
Condition
Chronic Kidney Diseases
Condition
Diabetes
Condition
Autoimmune Diseases
Condition
Inflammatory Disease
Condition
Tobacco Use
Intervention (Drug)
Cephalexin
Intervention (Drug)
Doxycycline
Intervention (Drug)
Cefadroxil
Lead sponsor
Mayo Clinic (class: other)

Record details

Record id
cardio:ct-nct04297592
Content hash
4f30871d6a7559910df29c2efe88516a7a59c94e730d2a316f444bfa653d800e